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Coronary  artery  disease  was  considered  a male  disease  for many  years.  However,  nowadays,  coronary
artery disease  constitutes  the  leading  cause  of  death  in  women,  although  there  are  a  lot  of gender-
related  differences  regarding  the  presentation  of acute  myocardial  infarction,  its diagnosis,  its  treatment,
short-  and long-term  mortality  rates,  and post-acute  myocardial  infarction  complications.  Generally,
women  have  smaller  and  stiffer  hearts  and cardiac  vessels,  suffering  a greater  extent  of atherosclerosis
and  endothelial  and  smooth  muscle  dysfunction.  They  are  usually  older  than  men  and  they  have  more
comorbidities  such  as hypertension,  renal  impairment,  and  diabetes  mellitus.  Moreover,  female  coronary
artery disease,  the  diagnosis  of which  is  more  complicated  due  to more  false  negative  results  of  some
diagnostic  methods  in  women,  is  more  often  presented  with atypical  symptoms  and  women’s  symptomsathophysiology
yocardial infarction
reatment
yocardium
of  typical  or atypical  angina  are  more  severe.  Furthermore,  women  delay  signiﬁcantly  more  in seeking
care  and they  are  more  frequently  undertreated.  Finally,  women  are  associated  with  generally  poorer  in-
hospital and  long-term  prognosis  having  almost  two-fold  higher  early  mortality  and  they  are  more  prone
to complications  such  as bleeding  complications,  shock,  and  heart  failure,  as well  as  to post-myocardial
infarction depression  and  poorer  physical  function  and  mental  health.  In this  review,  we  discuss  these
sex-related  differences  according  to  current  literature.
©  2013  Japanese  College  of  Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.
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For many years, there was an underestimation of the impor-
ance of coronary artery disease (CAD) in women [1]. Nowadays,
hough, coronary heart disease (CHD) is the leading cause of death
n women [1,2] killing approximately 400,000 of them per year in
he USA [2]. Either women older than 50 years experiencing typi-
al or atypical angina or women younger than 50 years with typical
ngina are classiﬁed as intermediate or high-risk patients for CHD
y the American Heart Association (AHA). On the other hand, no
ymptoms no matter the woman’s age means low risk for CAD
nless diabetes or peripheral artery disease is present [3].
In general, there are many sex-related differences with regard to
HD. Firstly, compared to men, older and smaller women are more
rone to hypertension, diabetes mellitus, hypercholesterolemia,
eripheral vascular disease, and unstable angina and have more
evere angina (Canadian Cardiovascular Society Class III–IV) [4].
oreover, despite women’s less extensive or less severe disease
mong patients with stable and unstable angina pectoris com-
ared to men, the former have more severe symptoms or they are
ore symptomatic independently of the extent of disease (1 or 2
r 3 vessels) [5]. Furthermore, although left ventricular (LV) sys-
olic dysfunction is less frequent in women, they more often have
ongestive heart failure [4]. Women  with CHD also receive less
ntensive treatment than men  [6], as their more increased home
nvironment obligations make them neglect health care needs [7].
o, despite a lower incidence of myocardial infarction and its later
resentation in women than in men, the former are associated with
igher mortality and morbidity rates [8]. Although men  experi-
nce coronary events four times more than women, women  are
ore likely to die after the ﬁrst episode of an acute myocardial
nfarction (AMI) [7]. Women  are generally characterized by higher
hort-term mortality than men  partly due to their higher age,
igher co-morbidity, and less aggressive treatment [9]. Moreover,
ender differences with regard to post-AMI mortality risk is even
ore apparent in young women compared with similarly aged men
10]. In addition, a signiﬁcantly higher prevalence of adverse out-
omes such as bleeding complications is reported in women after
eperfusion therapies [2,4,6]. Finally, women are more likely to be
idowed or live alone and more frequently suffer from depression,
o they less frequently return to their previous psychosocial status
fter an AMI  [7]. Herein, we are citing a review of the international
iterature reporting the sex differences with regard to each ﬁeld of
AD.
oncerning cardiac anatomy-biology
Females have smaller and stiffer hearts than males [11], as LV
ass is higher in men  than in women after puberty [12]. More-
ver, the female vasculature is also smaller and stiffer [4]. Although
hese sex differences could be attributed to the higher body surface
rea of men, the female LV mass [12], as well as the female coro-
ary artery diameters [1] appear to be lower even after adjusting
or different body size [1,12]. The aforementioned gender differ-
nces in ventricular and vascular size and stiffness may  explain
unctional differences between the genders [11], as well as the
igher perioperative mortality and higher periprocedural compli-
ation rates reported in women [1]. Increased coronary dissection
henomena [13], more complications at puncture site, and exagger-
ted leukocyte–platelet interactions caused by increased monocyte
issue factor expression in women are additional factors to put the
lame on for their higher periprocedural complications rates [1].
Moreover, the female vasculature presents a greater extent of
therosclerosis and endothelial and smooth muscle dysfunction [4].
ypertension, hypercholesterolemia, and diabetes mellitus, whichl of Cardiology 62 (2013) 4–11 5
are more prevalent in women lead to endothelial dysfunction [5].
Women  more frequently present with angina in exercise stress
tests despite their normal coronary angiograms (syndrome X) due
to endothelial dysfunction [14]. Adverse cardiovascular outcomes
in women  are also independently predicted by smooth muscle dys-
function, noted by the fact that intracoronary adenosine impairs
coronary ﬂow reserve [4]. Estrogens and their ﬂuctuations during a
woman’s life play a signiﬁcant role in these differences concerning
the vasculature [4]. NO which is responsible for vascular dilatation
is regulated by estrogens which inﬂuence the expression and activ-
ity of NO synthases resulting in higher availability of NO in women
compared with men  [11]. Estrogens also regulate lipid abnormali-
ties, mediating the hepatic lipoprotein metabolism [4]. Moreover,
female and male steroid hormones also regulate myocardial cal-
cium handling resulting in sex differences in cardiac function [11].
Finally, women’s vascular endothelial and smooth muscle cells
carry more functional receptors to bind estrogens than men  [15].
However, there is no abrupt rise in the prevalence of CAD in women
in comparison with men  at the time of menopause [4] and post-
menopausal hormone replacement therapy is contraindicated for
the prevention of cardiovascular events in women [3].
Finally, cardiac biomarkers also differ according to sex in
patients with acute coronary syndromes (ACS). Women are more
likely to have increased levels of C-reactive protein [4] and acute
phase brain natriuretic peptide [4], whereas men  have more
frequently elevated creatine kinase-MB and troponin levels [4].
Furthermore, women appear to have signiﬁcantly lower serum car-
diac troponin I after cardiac surgery compared to age- and risk
factor-matched men  [16].
Concerning prevalence of CAD
CAD presents 10 years later and the ﬁrst AMI  is delayed for
20 years in women compared to men  thanks to their known bio-
logical protection from CAD before menopause [17]. Men  younger
than 55 years old are almost four times more likely to experience a
myocardial infarction (MI) than women. Although this gender gap
decreases with increasing age, the prevalence of MI  remains lower
in women  throughout life [18], as no abrupt increase in CHD rates
for women occurs at the time of menopause [17]. Overall, 49% of
men and 32% of women over 40 years are at risk of CHD throughout
life [4].
Concerning risk factors
Hypertension [9,11,19,20], renal impairment [9,19], and dia-
betes mellitus [11,20] are more frequent among women. After
menopause, the total cholesterol level and the low-density lipopro-
tein (LDL)-cholesterol level increase, whereas the total level of
high-density lipoprotein (HDL)-cholesterol does not change and
the level of the HDL2 cholesterol decreases [21]. In general, exces-
sive consumption of fat and carbohydrates in combination with lack
of exercise and of time to rest results in overweight, dyslipidemia,
arterial hypertension, impaired glucose tolerance, and diabetes in
women [3]. Diabetic patients seem to be associated with lower
muscle strength and exercise tolerance at the beginning of car-
diac rehabilitation after coronary artery bypass graft (CABG) than
non-diabetic ones [22]. The former are also more prone to infection
and unregulated perioperative blood glucose after CABG leading to
higher mortality [23]. On the other hand, inferior wall involvement
[24], smoking [20,24], and previous history of MI  [20,24] are more
prevalent among men, although more and more women  smoke and
smoking and diabetes are related to a two- to four-fold greater risk
of coronary events in women [3]. A two-fold and four-fold greater
risk of reinfarction and heart failure respectively is also typical of
6 ourna
d
s
d
C
w
c
S
3
e
[
c
[
p
l
a
a
i
e
t
n
m
i
[
C
a
o
t
e
a
g
e
l
c
d
t
r
a
a
E
b
b
i
i
w
l
b
C
p
[
d
w
m
[
m
a N.A. Papakonstantinou et al. / J
iabetic women with MI  [17]. Additionally, a greater risk and more
evere impairment of myocardial metabolism is caused by obesity,
iabetes, and impaired glucose in women than in men  [11].
oncerning symptoms
Angina pectoris predominates at the onset of CHD in women,
hereas men’s CHD ﬁrst presentation is usually MI  or sudden
oronary death [17]. Moreover, according to the Coronary Artery
urgery Study (CASS), normal coronary angiograms accompanied
0% of women experiencing typical angina and 64% of them experi-
ncing atypical angina, against only 7% and 34% of men, respectively
25]. Angina symptoms along with normal coronary angiograms
onstitute syndrome X, which is more often observed in women
3]. On the contrary, silent myocardial ischemia that is the objective
resence of myocardial ischemia without angina or anginal equiva-
ents, predominates in men. So, when a woman has no symptoms at
ll, she is at low risk for CHD, unless she has diabetes or peripheral
rterial disease [3].
As far as the MI  presentation is concerned, although chest pain
s the most common symptom independently of gender, women
xperiencing an AMI are more likely to appear with atypical symp-
oms such as dyspnoea, abdominal, neck, and shoulder pain, or
ausea and vomiting [10,17]. Moreover, CAD is accompanied by
ore severe symptoms of typical or atypical angina in women than
n men  [5,26–28] for any given extent of disease (1 or 2 or 3 vessel)
5].
oncerning diagnosis
Many women with angina-like chest pain have normal coronary
ngiograms, so CHD cannot be diagnosed only by clinical history but
bjective evidence is required [17]. The most common objective
est for the estimation of myocardial ischemia is standard exercise
lectrocardiogram (ECG) testing. However, several factors – such
s smaller coronary arteries, fewer coronary artery lesions, sin-
le vessel disease, microvascular disease, vascular spasms, limited
xercise tolerance, artifacts because of breast, smaller LV size, a
ess augmented LV ejection fraction, an inappropriate release of
atecholamines and hormonal inﬂuences creating a false positive
igitalis-like image – may  inﬂuence this test in women leading
o a low sensitivity and speciﬁcity of approximately 60% and 70%
espectively and increased false-positive results [3]. Nevertheless,
 negative exercise ECG test has a high diagnostic value for the
bsence of signiﬁcant CHD [17]. The diagnostic accuracy of exercise
CG can be increased by myocardial perfusion imaging obtained
y myocardial scintigraphy or echocardiography [17]. However,
reasts and smaller female hearts also attenuate the perfusion
maging of myocardial activity. This adverse impact is more evident
n terms of tallium-201 scintigraphy, whereas it is nearly absent
hen 99m-Tc-sestamibi is used [3]. The diagnostic accuracy of the
atter is satisfactory and its sensitivity and speciﬁcity are similar
etween men  and women [3].
oncerning treatment
According to several studies, women delay presenting to hos-
ital to seek medical care after symptom onset longer than men
4,9,19,29–31]. However, several studies reported signiﬁcant sex
ifferences in prehospital delay only after the age of 65, whereas
omen < 65 years had similar delay duration compared to their
ale counterparts [29]. Moreover, according to Nguyen et al.
29], this sex proﬁle is reversed after the age of 75 years when
ales delay seeking medical care more than females. Addition-
lly, although men  are more likely to experience a Q-wave and/orl of Cardiology 62 (2013) 4–11
ST-elevation MI  (STEMI) than women  before the age of 75, there is
also a reverse with regard to this characteristic [29]. There are sev-
eral reasons why  there is a generally prolonged prehospital delay
among women. Firstly, the older the patient is, the more she/he
delays seeking medical care and it is known that a woman’s MI
onset takes place later compared to men. Secondly, atypical symp-
toms of AMI  are more frequent in women than men  [30]. Moreover,
women are poorly aware of AMI  symptoms and do not evaluate
them correctly, which is named “Yentl syndrome”, as heart attack
is wrongly considered a “male disease” [9,30]. Finally, women are
more frequently widowed or live alone when an MI  happens, tend
to face it by themselves or to ﬁrstly contact their physician, and
have more accompanying pathology such as diabetes, hyperten-
sion, and heart failure, than men  and all of these conditions appear
to be related to longer delay times [30].
Furthermore, the data obtained within recent years reveal
that women with CHD are less likely to undergo acute car-
diac interventions including coronary thrombolysis, coronary
angiography, coronary angioplasty, or CABG [4,10,32]. Addition-
ally, women  are not as frequently acutely and at discharge
treated with class I recommendations for medical therapy [4,33].
Diagnostic as well as treatment strategies tend to be less
aggressive in women  suffering from CHD than in men  [1].
Surprisingly, evidence-based cardiovascular treatment includ-
ing secondary prevention drugs (angiotensin-converting enzyme
inhibitors/angiotensin receptor blockers, dual platelet inhibition
and statins, aspirin, and beta-blockers) was offered to 14–25%
less women, according to Lawesson et al. [6]. However, several
studies report that women with advanced CAD receive per-
cutaneous coronary intervention (PCI) to the same extent as
men  [4].
Concerning post-AMI mortality
Special attention should be paid to female MI due to women’s
generally poorer in-hospital and long-term prognosis compared
to men  [3] (Table 1). Women  are generally recognized to have a
higher (even two-fold higher) early mortality after AMI compared
to men  [1,3,9,17,19,28,31,33–36]. Differences in age, comorbid-
ity, prehospital delay, and treatment approaches are responsible
to an extent for making women  more prone to poor progno-
sis after an AMI  [1]. Nevertheless, after adjustment for factors
such as differences in medical history, the extent of the infarc-
tion, and early therapeutic intervention women continued to
be more likely to die for every 5 years of decreasing age,
according to Vaccarino et al. [28]. Moreover, the gender gap
with regard to short-term mortality rates decrease with increas-
ing age [28]. Vaccarino et al. [28] reported that women < 50
years old were more than twice as likely as their male age-
matched counterparts to die. A two-fold higher mortality in
women < 65 years compared to men  was  also reported by Till-
manns et al. [1]. Similar results were also shown by MacIntyre
et al. [37], who  found a signiﬁcantly higher 30-day case fatal-
ity in women (6.5%) when compared to age-matched men (4.8%).
Finally, according to the National Acute Myocardial Infarction
in Sweden only women  under 50 had a worse prognosis than
men  [18]. This sex difference in early mortality is eliminated
after the age of 74 years [28] or even reversed in favor of
women > 75 years [37]. On the other hand, several studies report
similar long-term mortality between the genders after adjust-
ment for age [9,18,19]. According to another study, even women
who were older and had more risk factors, compared to men,
did not have a greater risk of long-term mortality after complete
revascularization [38].
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Table  1
Early mortality after acute myocardial infarction.
Early mortality after acute myocardial infarction
Study No. of patients Mortality Women  Men  p-Value
Stone et al., PAMI trial [34] 107 women, 288 men  In-hospital 9.3% 2.8% 0.005
MITRA registry [19] 6067 patients In-hospital 20.9% 12.3% <0.01
Theres et al. [31] 1803 women, 3330 men  In-hospital 18.6% 8.4% <0.01
Butala et al. [33] 253 women, 951 men In-hospital 17% 8.9% <0.01
ISIS-3 [35] 9600 women, 26,480 men  35-Day 14.8% 9.1% <0.01
NRMI-2 [28] 155,565 women, 229,313 men In-hospital 16.7% 11.5% <0.001
Conti  et al. [58] 54 women, 182 men  In-hospital 5.5% 3.3% ns
AMIS  Plus registry [36] 5633 women, 14,657 men  In-hospital 10.7% (STEMI: 13.0%, non-STEMI: 7.5%) 6.3% (STEMI: 7.2%, non-STEMI: 4.9%) <0.001
Zimmermann et al. [9] 161 women, 405 men  In-hospital 8.7% 7.2% ns
Table 2
Early and long-term mortality after thrombolysis.
Mortality after thrombolysis
Study No. of patients Mortality Women  Men  p-Value
Gusto-I trial [39] 543 women, 1887 men 30-Day 13.1% 4.8% ≤0.0001
TIMI  II trial [40] 6-Week 9% 4% 0.01
RESCATE trial [32] 331 women, 1129 men
28-Day 18.5% 8.3% <0.001
6-Month 25.8% 10.8% <0.001
GISSI  trial [59] 11,712 patients 1-Year 29.8% 15.2% <0.01
Motovska et al., PRAGUE 1 and 2 trials [41] 520 patients 30-Day 15% 9% 0.043
Stone  et al., PAMI trial [34] 107 women, 288 men In-hospital 14% 3.5% 0.006
 in 50
A
w
p
d
t
t
(
a
m
T
EIshihara et al. [20] 564 patients (thrombolysis
fter thrombolysis
Thrombolytic reperfusion tends to be performed less in
omen than men. Moreover, higher rates of bleeding com-
lications and short-term mortality are related to the former,
espite the 25–30% reduction in early mortality that coronary
hrombolysis has offered [1,37]. So, women still die almost
wice as often as men  after thrombolysis [20,32,34,39–41]
Table 2). Furthermore, gender independently inﬂuences even
ge- and clinical and angiographic variables-adjusted 30-day
ortality [39].
able 3
arly mortality after primary PCI.
Early mortality after primary PCI
Study No. of patients 
Cowley et al., NHLBI PTCA
registry [48]
705 women, 2374 men 
Kelsey et al., 1985–1986
NHLBI PTCA registry [13]
546 women, 1590 men  
Malenka et al. [45] 12,232 patients 
Motovska et al., PRAGUE 1
and 2 trials [41]
530 patients 
Stone  et al., PAMI trial [34] 107 women, 288 men  
Bell  et al. [44] 3557 patients, 27% women
Arnold et al. [43] 1274 women, 3726 men  
Vakili  et al. [47] 317 women, 727 men  
Watanabe et al. [46] 118,548 angioplasties (36% in women) 
AMIS  Plus registry [36] 
Zimmermann et al. [9] 517 patients 
Giessen study [1] 178 women, 513 men  
Keelan et al. [50] 941 women, 2073 men  
Lawesson et al., SWEDEHEART
register [6]
Early period (1998–2000): 5546 women, 10,151 men
Late  period (2004–2006): 4994 women, 9386 men  %) 3-Year 27% 18% 0.03
After PCI
Since 2003, the European Society of Cardiology guidelines [42]
recommend primary angioplasty (PCI) after STEMI thanks to its
proven superiority against thrombolysis in reducing mortality.
Over the past years, women  as well as men have obviously
beneﬁted from PCI [2]. Short-term results on mortality after
PCI, though, are signiﬁcantly worse in women compared to men
[6,13,36,43–49]. Even in studies suggesting non-signiﬁcant gender
differences with regard to short-term mortality, women  had lower
survival rates after PCI [1,9,34,41,50] (Table 3). On the other hand,
Mortality Women  Men  p-Value
Periprocedural 1.7% 0.3% 0.001
Procedural 2.6% 0.3% 0.001
In-hospital 1.64% 0.7% 0.01
30-Day 8.2% 6.2% 0.409 (ns)
In-hospital 4.0% 2.1% 0.46 (ns)
In-hospital 4.2% 2.7% 0.005
Periprocedural between 1979 and 1987 1.0% 1.2% ns
Periprocedural between 1988 and 1990 2.9% 1.4% 0.02
Procedural 1.1% 0.3% 0.001
In-hospital 7.9% 2.3% 0.05
After stenting 4.0% 2.0% 0.0001
30-Day 4.2% 3.0% 0.018
30-Day 8.4% 5.6% ns
30-Day 6.2% 6.0% ns
In-hospital 4.1% 3.2% ns
 In-hospital 14.5% 8.3% <0.001
In-hospital 10.4% 4.9% <0.001
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Table 4
Long-term mortality after PCI.
Long-term mortality after primary PCI
Study No. of patients Mortality Women  Men  p-Value
Lawesson et al.,
SWEDEHEART
register [6]
Early period (1998–2000):
5546 women, 10,151 men
1-Year 23.9% 15.5% <0.001
Late  period (2004–2006):
4994 women, 9386 men
1-Year 19.1% 10.3% <0.001
Katayama et al. [49] 120 women, 264 men 6-Month 11% 5% 0.02
Keelan et al. [50] 941 women, 2073 men  6-Year 19% 15% ns
BARI  trial [27] 489 women, 1340 men  5-Year 12.8% 12% ns
Giessen study [1] 204 women, 577 men
6-Month 9.5% 8.0% 0.6 (ns)
1-Year 12.5% 9.0% 0.1 (ns)
2-Year 14.5% 10.5% 0.2 (ns)
3-Year 18.0% 12.0% 0.07 (ns)
4-Year 23.0% 15.0% 0.04
Singh  et al. [2]
Early group (1979–1995):
2203 women, 5701 men
5-Year 21.0% 17.0% ns
Late  group (1996–2004):
3365 women, 7616 men
5-Year 19.0% 17.0% ns
Ishihara et al. [20]
678 patients (balloon PCI
angioplasty in 71%) 3-Year
23% 15% 0.048
742  patients (stent in 66%) 12% 10% 0.66 (ns)
Sato  et al. [38]
274 women, 1562 men
11.4 ± 2.9 years 412 patients died from all causes, 0.305 (ns) (all-cause
l
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p(either PCI or CABG)
ong-term survival rates seem to be similar between the genders,
specially after the appropriate adjustment for risk factors and
omorbidity [1,2,27,38,44,50] (Table 4). Similarly, Ishihara et al.
ound no signiﬁcant difference in three-year mortality between
ales and females having undergone angioplasty mainly with
tents. However, female sex was associated with signiﬁcantly
igher three-year mortality when balloon angioplasty was  mainly
erformed in the same study [20]. Moreover, according to the
iessen study, the general trend for a higher mortality in women
eached signiﬁcance only 4 years after PCI performance [1,2].
fter CABG
Generally, women are at higher mortality risk after CABG than
en  [26,51–53] (Table 5). In-hospital mortality after CABG has
een shown to be up to twice as high in women than men  [3].
emale characteristics such as older age, smaller body size and
oronary lumen, and higher incidence of comorbidities (diabetes,
ystemic hypertension, and hypercholesterolemia) are responsible
or this gender gap [3]. According to Edwards et al. [53], female
ender is an independent predictor of greater CABG operative mor-
ality except in very high-risk categories, where male and female
ortality rates are similar. Furthermore, women make a more
ifﬁcult recovery after CABG than men  [26]. Nonetheless, Rahim-
oola et al. suggest that older age, previous CABG, previous MI,
nd diabetes are independent risk factors for higher mortality,
ut gender is not [51]. The Bypass Angioplasty Revasculariza-
ion Investigation (BARI) group observed no gender differences
n early and late mortality after percutaneous transluminal coro-
ary angioplasty and CABG comparing 489 women to 1340 men
27]. Sato et al. [38] also found no signiﬁcant gender difference
n long-term mortality after CABG. Vaccarino et al. [26] reported
hat the older the patients’ age was, the less the gender differ-
nces were. Finally, Puskas et al. [54] comparing on-pump CABG
ONCAB) to off-pump CABG (OPCAB), observed that the latter
lunted gender differences in clinical outcomes after CABG, as
atients treated with OPCAB had a signiﬁcantly lower incidence of131 patients died from cardiac
causes, no signiﬁcant gender
differences
mortality)
0.562 (ns) (cardiac
mortality)
mortality and other adverse outcomes and this was more apparent
in females.
Concerning complications
Post-MI non-fatal adverse outcomes including bleeding com-
plications – particularly intracranial hemorrhage –, shock, heart
failure, stroke, and reinfarction are generally more frequent in
women than men  [1,6,9,17,39,47,55]. In fact, according to the Pri-
mary Angioplasty in Myocardial Infarction (PAMI-1) trial, 5.3% of
women experienced intracranial bleeding against only 0.7% of men
(p = 0.037) [34]. Moreover, the United States National Registry of
Myocardial Infraction (NRMI) reported death due to cardiac rupture
is more possible in women, whereas cardiac arrhythmia-caused
death predominates in men  [17]. Older age, lower body surface
area, smaller coronary arteries, more risk factors, and more fre-
quent comorbidities in women are some factors to put the blame
on for their superiority to men  in complications [2].
Compared to men, women are at higher risk for vascular
and bleeding complications (such as access-site hematomas and
retroperitoneal bleeds) and for red blood cell transfusion require-
ment [4], which appears as an independent risk factor for 30-day
mortality [9]. In fact, within CRUSADE, women were more prone
to bleeding risk attributable to dosing than men  (25% versus 4.4%
respectively) [55]. Zimmermann et al. [9] reported that 16.8% of
women against 5.9% of men  received blood transfusion after PCI
(p = 0.001). Women’s lower body weight and reduced glomerular
ﬁltration rates predisposing to excess dosing of anticoagulants and
antiaggregatory drugs [4,9] and their smaller and stiffer vascula-
ture are possible reasons why  vascular and bleeding complications
as well as transfusion necessity are more frequent in women [4].
Moreover, pulmonary edema and cardiogenic shock are also
more prevalent in women  [4,32]. After shock has developed,
though, the outcome is independent of sex [4]. Women  are also
more prone to heart failure during their hospital stay after PCI
[4,9,19,27,49], which constitutes an independent predictor of in-
hospital mortality in both genders undergoing revascularization
[4,27]. A possible explanation is the greater inability of smaller and
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stiffer hypertrophied female hearts to tolerate the volume changes
and transient ischemic periods occurring during PCI [4]. Reinfarc-
tion also has a greater prevalence in women than in men  [3,17].
Finally, although perioperative MI  is a more frequent complication
after cardiac surgery in men, AMIs in women have a notable impact
on excess mortality and ICU stay [8].
Concerning psychosocial impact
Men  have the advantage against women with regard to health-
related quality of life (HRQL) including patients’ sentiments after
an acute cardiac event and their present and future expectations
[7]. Likewise, compared to men, women experiencing an AMI are
more prone to poorer physical function and mental health [7], to
later return to work, and to less frequent participation in cardiac
rehabilitation programs [10]. Moreover, post-MI depression which
is independently related to higher mortality, rehospitalization, and
worse functional status and quality of life is more prevalent in
women than in men. Therefore, the women’s excess risk after an
MI is also partly attributable to their more frequent depressive
symptoms [56].
Conclusions
In conclusion, women do have CHD and the rate of coronary
death is twice higher in women than in men  after MI  and revas-
cularization procedures [3]. There are deﬁnitely a lot of gender
differences regarding the presentation of AMI, its diagnosis, its
treatment, short- and long-term mortality rates, and post-AMI
complications. Women  are usually older, have more comorbidities,
delay signiﬁcantly more in seeking care, appear more frequently
with atypical symptoms, are usually related to higher short-term
mortality rates, and are more prone to complications such as
bleeding complications, shock, and heart failure. Some diagnostic
methods are associated with more false-negative results in women,
so they should be carefully evaluated for coronary symptoms [3].
The American College of Cardiology/American Heart Association
guidelines concerning the treatment of STEMI recommend that
suitable for revascularization shock patients <75 years old should
receive early PCI revascularization or coronary bypass surgery
which also constitute reasonable treatment approaches for selected
shock patients ≥75 years old independently of sex [57]. Neverthe-
less, women appear less likely to receive treatment for CHD than
men  [3]. Consequently, a better compliance with treatment guide-
lines in women is a sine qua non toward our effort to diminish this
gender gap concerning the outcome after an MI [6].
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